Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,713 | -23,208 | -7,195 | -3,534 | -10,987 |
| Depreciation Amortization | 540 | 409 | 275 | 138 | 562 |
| Accounts receivable | -612 | 1,210 | 1,499 | 1,509 | N/A |
| Other Working Capital | -1,505 | 15,041 | 1,168 | -669 | -2,827 |
| Other Operating Activity | 12,575 | 823 | -255 | -887 | 883 |
| Operating Cash Flow | $-26,715 | $-5,725 | $-4,508 | $-3,443 | $-12,369 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -2 | -3 | N/A | 0 |
| Investing Cash Flow | $-11 | $-2 | $-3 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 43,191 | 0 | 0 | N/A | N/A |
| Other Financing Activity | 0 | -638 | -517 | 0 | 13,194 |
| Financing Cash Flow | $43,191 | $-638 | $-517 | $N/A | $13,194 |
| Beginning Cash Position | 8,277 | 8,278 | 8,277 | 8,277 | 7,452 |
| End Cash Position | 24,742 | 1,913 | 3,249 | 4,834 | 8,277 |
| Net Cash Flow | $16,465 | $-6,365 | $-5,028 | $-3,443 | $825 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,715 | -5,725 | -4,508 | -3,443 | -12,369 |
| Capital Expenditure | -11 | -2 | -3 | N/A | N/A |
| Free Cash Flow | -26,726 | -5,727 | -4,511 | -3,443 | -12,369 |